-+ 0.00%
-+ 0.00%
-+ 0.00%

MERCK & CO INC: INTISMERAN PLUS KEYTRUDA SIGNIFICANTLY REDUCED THE RISK OF RECURRENCE OR DEATH BY 42% COMPARED TO KEYTRUDA ALONE

Reuters·10/22/2026 18:22:57

Please log in to view news